The Modesto Bee Local Stock Index
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Arena Pharmaceuticals, Inc. (NQ: ARNA)
7.990 USD  +0.030 (+0.38%)
Official Closing Price  /  Updated: 5:20 PM EDT, May 21, 2013  /  Add to My Watchlist      
View: Quote News Research
All news about Arena Pharmaceuticals, Inc.
 
< Previous 1 2 3 4 5 6 7 8 9
...
70 71 Next >
Today’s Research on CELG, ARNA, INCY, SPPI, and GERN
Today 10:55 EDT
from ACCESSWIRE
Enteromedics Rallies On Confirmed Path To Possible Approval
May 20, 2013
EnteroMedics (NASDAQ: ETRM) is a company that focuses on gastrointestinal and metabolic diseases with its flagship product VBLOC®, which is a first-in-class weight loss treatment that prevents obesity... Read More
category ETRM , Bio/Wire
from Bio-Wire.Com
Post Earnings Update: Arena Pharmaceuticals Has Sunk 5.0% Lower in Past 2 Weeks (ARNA)
May 20, 2013
from Comtex SmarTrend® News Briefs
Art Pappas Elected to NVCA Board of Directors
May 15, 2013
from PR Newswire
Short Interest in Vertex Rises, in Celgene Falls
May 11, 2013
The short interest moves in biotech and emerging pharmaceutical companies were mixed in the latter two weeks of April. The number of shares sold short in Dendreon (NASDAQ: DNDN ), Gilead Sciences... Read More
category Regeneron Pharmaceuticals , amgen , Benzinga , and 35 more.
from Latest Articles from Benzinga.com
Why Does Arena's Obesity Drug Have Abuse Potential?
May 11, 2013
A cautious DEA meets a cautiously optimistic FDA Read More
category TOKYO:ESALY , NASDAQ:OREX , NASDAQ:ARNA , and 1 more.
from Forbes Real Time
Arena Pharmaceuticals to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
May 10, 2013
from PR Newswire
1 Stock to Buy, 1 Stock to Short: Pharmaceuticals
May 10, 2013
 Read More
category OTCBB:ELTP , NASDAQ:ARNA
from InvestorPlace - Latest Headlines
The New Diet Pill Players: Arena and Vivus
May 08, 2013
category AZN , ARNA , ABT , and 1 more.
from YCharts
Will The Prescription Diet Pill Market Finally Bulk Up?
May 08, 2013
Over the past 24 hours, two developments finally occurred to suggest overweight consumers will soon have an expanding choice of prescription diet pill options. First, Arena Pharmaceuticals disclosed... Read More
category NASDAQ:OREX , NASDAQ:ARNA , NASDAQ:VVUS
from Forbes Real Time
Streetinsider.com's Hot Lunchtime Reads 05/08: (DDD) (LAZ) (VCLK) (MDLZ)
May 08, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8317297 for the full story. Read More
from StreetInsider.com News Articles
VIVUS, Inc. (VVUS) Pops as Larger Qsymia Retail Presence Expected Soon
May 08, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8317224 for the full story. Read More
from StreetInsider.com News Articles
UPDATE 2-Vivus in talks with large pharma cos for diet drug tie-up; shares rise
May 08, 2013
* Qsymia to be available in retail pharmacies from mid-July Read More
category companyNews
from Reuters: Company News
Option Bulls Jump on Arena Pharmaceuticals, Inc. (ARNA)
May 08, 2013
Bullish bets were unusually popular on Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) yesterday, with call volume on the drug stock rising to more than three times the expected level...( Read More ) Read More
category ARNA
from SchaeffersResearch.com Daily Market Blog
Free Research Reports on AMRI, ARNA, MKTG and SCTY Issued by the Paragon Report
May 08, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT Read More
from Marketwired News Releases
JCPenney Same-Store Sales Sink: 6 Stocks in 60 Seconds
May 08, 2013
 Read More
category NYSEARCA:SPY , NYSE:JCP , NASDAQ:GRPN , and 3 more.
from InvestorPlace - Latest Headlines
Record Day For Dow, S&P 500
May 07, 2013
The Dow closed above the 15,000 mark for the first time by climbing 87 points to 15,056. Nasdaq rose 3 points to 3396. Read More
category Market News
from MarketMinute.com Market Updates
Stocks Crossing 50-Day SMA 05/07: (PFE) (JPM) (ARNA) Above; (FTR) (GGB) (ORCL) Below
May 07, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8313325 for the full story. Read More
from StreetInsider.com News Articles
Arena (ARNA) Confirms BELVIQ Will Soon Be Available for Sale in the U.S.
May 07, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8313240 for the full story. Read More
from StreetInsider.com News Articles
UPDATE: Arena Pharma Issues Update on Upcoming US Launch of BELVIQ, to Get $65M Milestone Payment from Eisai
May 07, 2013
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) announced today that the Office of the Federal Register filed for public inspection the US Drug Enforcement Administration's (DEA) final rule placing BELVIQ... Read More
category Benzinga , ARNA , News , and 1 more.
from Latest Articles from Benzinga.com
Arena Pharmaceuticals Provides Update on Upcoming US Launch of BELVIQ® (lorcaserin HCl) for Chronic Weight Management
May 07, 2013
-- Arena to Receive $65 Million in Milestone Payments from Eisai -- Read More
from PR Newswire
Streetinsider.com's Hot Lunchtime Reads 05/07: (NOK) (GLD) (FSLR) (TSLA) (ARNA)
May 07, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8312449 for the full story. Read More
from StreetInsider.com News Articles
Arena (ARNA) Clears Final BELVIQ Marketing Hurdle; Could Make U.S. Debut in June
May 07, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8312432 for the full story. Read More
from StreetInsider.com News Articles
Belviq Is Not the Next Fen-Phen … Probably
May 07, 2013
 Read More
category Hot Stocks , NASDAQ:ARNA
from InvestorPlace - Latest Headlines
Arena & VIVUS Weaken On Poor Obesity Drug Prospects In Europe
May 07, 2013
Arena & VIVUS Weaken On Poor Obesity Drug Prospects In Europe Responding to news that the company would withdraw its MAA (Marketing Authorization Application) for Belviq (lorcaserin) from the EMA... Read More
category ARNA , Bio/Wire , VVUS
from Bio-Wire.Com
Arena Pharmaceuticals (ARNA) - Market Review
May 07, 2013
NEW YORK (AVAFIN) -- Arena Pharmaceuticals options set a new 90-day record for the ... Read More
from AVAFIN
Bio-Wire Weekly: April 29 – May 3rd, 2013
May 06, 2013
Bio-Wire Weekly: April 29 – May 3rd, 2013 To get this email earlier, sign up for our email list The Newsmakers: 1.) Auxilium Pharmaceuticals (NASDAQ: AUXL) Auxilium Pharma was down about 8% in the last... Read More
category Prime Content , AEGR , REGN , and 5 more.
from Bio-Wire.Com
Free Research Reports on ARNA, REGN, THOR and TWO Issued by the Bedford Report
May 06, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the Equity News Circuit Read More
from Marketwired News Releases
Squawk Box Stocks Reports On: Ford Motor Co. (NYSE: F), Weatherford International Ltd. (NYSE: WFT), Central European Media Enterprises Ltd. (NASDAQ: CETV), Arena Pharmaceuticals, Inc. (NASDAQ: ARNA)
May 06, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the Equity News Circuit Read More
from Marketwired News Releases
Vivus and QSYMIA: Tailwinds but Significant Uncertainty Remains
May 06, 2013
Since peaking over $28 in July 2012 at the height of enthusiasm over its lead compound QSYMIA, Vivus (NASDAQ: VVUS) has pulled back by over 50 % as early prescription data came in far below... Read More
category ARNA , VVUS
from Bio-Wire.Com
< Previous 1 2 3 4 5 6 7 8 9
...
70 71 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here